Reduction of the Occurrence of Acute Cellular Rejection Among Renal Allograft Recipients Treated With Basiliximab, a Chimeric Anti-interleukin-2-receptor Monoclonal Antibody1,2
Year: 1999
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Transplantation
Authors: Barry D. Kahan, P. R. Rajagopalan, Michael Hall
Language: English
Subfield: Transplantation
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2123720448
